ArticleJournal for immunotherapy of cancer2018

Atypical response with bone pseudoprogression in a patient receiving nivolumab for advanced cutaneous squamous cell carcinoma.

Leandro J C Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.